Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk: Meta-Analysis of 119 Clinical Trials Involving 100 667 Patients

Peter Willeit*, Lena Tschiderer, Elias Allara, Kathrin Reuber, Lisa Seekircher, Lu Gao, Ximing Liao, Eva Lonn, Hertzel C. Gerstein, Salim Yusuf, Frank P. Brouwers, Folkert W. Asselbergs, Wiek van Gilst, Sigmund A. Anderssen, Diederick E. Grobbee, John J. P. Kastelein, Frank L. J. Visseren, George Ntaios, Apostolos I. Hatzitolios, Christos SavopoulosPythia T. Nieuwkerk, Erik Stroes, Matthew Walters, Peter Higgins, Jesse Dawson, Paolo Gresele, Giuseppe Guglielmini, Rino Migliacci, Marat Ezhov, Maya Safarova, Tatyana Balakhonova, Eiichi Sato, Mayuko Amaha, Tsukasa Nakamura, Kostas Kapellas, Lisa M. Jamieson, Michael Skilton, James A. Blumenthal, Alan Hinderliter, Andrew Sherwood, Patrick J. Smith, Michiel A. van Agtmael, Peter Reiss, Marit G. A. van Vonderen, Stefan Kiechl, Gerhard Klingenschmid, Matthias Sitzer, Coen D. A. Stehouwer, Heiko Uthoff, Zhi-Yong Zou, PROG-IMT and the Proof-ATHERO Study Groups

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

39 Citations (Web of Science)
Original languageEnglish
Pages (from-to)621-642
Number of pages22
JournalCirculation
Volume142
Issue number7
DOIs
Publication statusPublished - 18 Aug 2020

Keywords

  • cardiovascular disease
  • carotid intima-media thickness
  • clinical trials as topic
  • surrogate marker
  • meta-analysis
  • BASE-LINE CHARACTERISTICS
  • TYPE-2 DIABETES-MELLITUS
  • IMPAIRED GLUCOSE-TOLERANCE
  • CORONARY-HEART-DISEASE
  • JAPAN STATIN TREATMENT
  • LDL TREATMENT STRATEGIES
  • EXTENDED-RELEASE NIACIN
  • ESTROGEN PLUS PROGESTIN
  • ARTERIAL-WALL THICKNESS
  • HIV-INFECTED PATIENTS

Cite this